Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 6231 

accumulating 1.8 million miles. He 

holds a Class A CDL from Georgia. His 

driving record for the last 3 years shows 

no crashes and no convictions for 

moving violations in a CMV. 

Kamaljit S. Dhillon 

Mr. Dhillon, 48, has had complete 

vision loss in his left eye due to a 

traumatic incident in 1994. The visual 

acuity in his right eye is 20/20, and in 

his left eye, no light perception. 

Following an examination in 2021, his 

optometrist stated, ‘‘His vision and his 

field of vision in his right eye are 

excellent and he can therefore safely 

operate a commercial vehicle.’’ Mr. 

Dhillon reported that he has driven 

straight trucks for 10 years, 

accumulating 680,000 miles, and 

tractor-trailer combinations for 6 years, 

accumulating 68,000 miles. He holds a 

Class A CDL from Ohio. His driving 

record for the last 3 years shows no 

crashes and one conviction for a moving 

violation in a CMV; failing to obey a 

traffic device. 

Michael P. Gross 

Mr. Gross, 49, has had amblyopia in 

his left eye since childhood. The visual 

acuity in his right eye is 20/20, and in 

his left eye, 20/50. Following an 

examination in 2021, his optometrist 

stated, ‘‘I certify that, in my medical 

opinion, Mr. Gross does have sufficient 

visual performance to perform the 

visual tasks necessary to operate a 

commercial vehicle.’’ Mr. Gross 

reported that he has driven straight 

trucks for 25 years, accumulating 25 

million miles, and tractor-trailer 

combinations for 6 years, accumulating 

30 million miles. He holds a Class A 

CDL from Utah. His driving record for 

the last 3 years shows no crashes and no 

convictions for moving violations in a 

CMV. 

James Mize 

Mr. Mize, 33, has optic atrophy in his 

left eye since childhood. The visual 

acuity in his right eye is 20/20, and in 

his left eye, 20/400. Following an 

examination in 2021, his 

ophthalmologist stated, ‘‘In my medical 

opinion, James Mize has sufficient 

vision to perform the driving tasks 

required to operate a commercial 

vehicle.’’ Mr. Mize reported that he has 

driven straight trucks for 6 years, 

accumulating 60,000 miles. He holds a 

Class A CDL from Tennesse. His driving 

record for the last 3 years shows no 

crashes and no convictions for moving 

violations in a CMV. 

Eugene F. Napieralski 

Mr. Napieralski, 57, has complete 

vision loss in his left eye since birth. 

The visual acuity in his right eye is 20/ 

20, and in his left eye, no light 

perception. Following an examination 

in 2021, his optometrist stated, ‘‘In my 

professional opinion, Mr. Napieralski 

has sufficient vision to perform the 

driving tasks required to operate a 

commercial vehicle.’’ Mr. Napieralski 

reported that he has driven straight 

trucks for 38 years, accumulating 

950,000 miles, and tractor-trailer 

combinations for 2 years, accumulating 

20,000 miles. He holds a Class A CDL 

from Minnesota. His driving record for 

the last 3 years shows no crashes and no 

convictions for moving violations in a 

CMV. 

Gerard L. Pagan 

Mr. Pagan, 61, has had amblyopia in 

his left eye since childhood. The visual 

acuity in his right eye is 20/20, and in 

his left eye, 20/100. Following an 

examination in 2021, his optometrist 

stated, ‘‘I certify that upon examining 

Jerry Pagan on 9/9/2021, he has 

sufficient vision to perform the driving 

tasks required to operate a commercial 

vehicle.’’ Mr. Pagan reported that he has 

driven tractor-trailer combinations for 

25 years, accumulating 2 million miles. 

He holds a Class A CDL from North 

Carolina. His driving record for the last 

3 years shows one crash, which he was 

not cited for, and no convictions for 

moving violations in a CMV. 

Sheryl J. Simpson 

Ms. Simpson, 58, has had amblyopia 

in her left eye since childhood. The 

visual acuity in her right eye is 20/25, 

and in her left eye, 20/50. Following an 

examination in 2021, her optometrist 

stated, ‘‘In my medical opinion, Sheryl 

has more than sufficient vision to 

perform the driving tasks required to 

operate a commercial vehicle.’’ Ms. 

Simpson reported that she has driven 

buses for 8 years, accumulating 704,000 

miles. She holds a Class B CDL from 

Texas. Her driving record for the last 3 

years shows no crashes and no 

convictions for moving violations in a 

CMV. 

Willie J. Smith 

Mr. Smith, 64, has corneal opacity in 

his right eye due to a traumatic incident 

in 1985. The visual acuity in his right 

eye is hand motion, and in his left eye, 

20/25. Following an examination in 

2021, his optometrist stated, ‘‘It is my 

medical opinion that the patient has 

sufficient vision to perform the driving 

tasks required to operate a commercial 

motor vehicle.’’ Mr. Smith reported that 

he has driven tractor-trailer 

combinations for 40 years, accumulating 

2.4 million miles. He holds a Class A 

CDL from Texas. His driving record for 

the last 3 years shows no crashes and 

one conviction for a moving violation in 

a CMV: speeding. 

IV. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments and material received before 

the close of business on the closing date 

indicated under the DATES section of the 

notice. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–02204 Filed 2–2–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2021–0026] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of applications for 

exemption; request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from 32 individuals for an 

exemption from the prohibition in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) against persons 

with a clinical diagnosis of epilepsy or 

any other condition that is likely to 

cause a loss of consciousness or any loss 

of ability to control a commercial motor 

vehicle (CMV) to drive in interstate 

commerce. If granted, the exemptions 

would enable these individuals who 

have had one or more seizures and are 

taking anti-seizure medication to 

operate CMVs in interstate commerce. 

DATES: Comments must be received on 

or before March 7, 2022. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System (FDMS) Docket No. 

FMCSA–2021–0026 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number, FMCSA–2021–0026, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 


khammond on DSKJM1Z7X2PROD with NOTICES
6232 Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

and click on the ‘‘Comment’’ button. 

Follow the online instructions for 

submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE, Washington, DC 

20590–0001 between 9 a.m. and 5 p.m., 

ET, Monday through Friday, except 

Federal Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are 8:30 a.m. to 5 p.m., ET, 

Monday through Friday, except Federal 

holidays. If you have questions 

regarding viewing or submitting 

material to the docket, contact Dockets 

Operations, (202) 366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2021–0026), 

indicate the specific section of this 

document to which each comment 

applies, and provide a reason for each 

suggestion or recommendation. You 

may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

www.regulations.gov/docket?D=FMCSA2021-0026. Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, click the ‘‘Comment’’ 

button, and type your comment into the 

text box on the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit 

comments by mail and would like to 

know that they reached the facility, 

please enclose a stamped, self-addressed 

postcard or envelope. 

FMCSA will consider all comments 

and material received during the 

comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number, FMCSA–2021–0026, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

and click ‘‘Browse Comments.’’ If you 

do not have access to the internet, you 

may view the docket online by visiting 

Dockets Operations in Room W12–140 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m., ET, Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

C. Privacy Act 

In accordance with 5 U.S.C. 553(c), 

DOT solicits comments from the public 

to better inform its regulatory process. 

DOT posts these comments, without 

edit, including any personal information 

the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.transportation.gov/privacy. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. The 

statute also allows the Agency to renew 

exemptions at the end of the 5-year 

period. FMCSA grants medical 

exemptions from the FMCSRs for a 2- 

year period to align with the maximum 

duration of a driver’s medical 

certification. 

The 32 individuals listed in this 

notice have requested an exemption 

from the epilepsy and seizure disorders 

prohibition in 49 CFR 391.41(b)(8). 

Accordingly, the Agency will evaluate 

the qualifications of each applicant to 

determine whether granting the 

exemption will achieve the required 

level of safety mandated by statute. 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners (MEs) in 

determining whether drivers with 

certain medical conditions are qualified 

to operate a CMV in interstate 

commerce. 

The criteria states that if an individual 

has had a sudden episode of a nonepileptic seizure or loss of 

consciousness of unknown cause that 

did not require anti-seizure medication, 

the decision whether that person’s 

condition is likely to cause the loss of 

consciousness or loss of ability to 

control a CMV should be made on an 

individual basis by the ME in 

consultation with the treating physician. 

Before certification is considered, it is 

suggested that a 6-month waiting period 

elapse from the time of the episode. 

Following the waiting period, it is 

suggested that the individual have a 

complete neurological examination. If 

the results of the examination are 

negative and anti-seizure medication is 

not required, then the driver may be 

qualified. 

In those individual cases where a 

driver has had a seizure or an episode 

of loss of consciousness that resulted 

from a known medical condition (e.g., 

drug reaction, high temperature, acute 

infectious disease, dehydration, or acute 

metabolic disturbance), certification 

should be deferred until the driver has 

recovered fully from that condition, has 

no existing residual complications, and 

is not taking anti-seizure medication. 

Drivers who have a history of 

epilepsy/seizures, off anti-seizure 

medication and seizure-free for 10 years, 

may be qualified to operate a CMV in 

interstate commerce. Interstate drivers 

with a history of a single unprovoked 

seizure may be qualified to drive a CMV 

in interstate commerce if seizure-free 

and off anti-seizure medication for a 5- 

year period or more. 

As a result of MEs misinterpreting 

advisory criteria as regulation, 

numerous drivers have been prohibited 

from operating a CMV in interstate 

commerce based on the fact that they 

have had one or more seizures and are 

taking anti-seizure medication, rather 

than an individual analysis of their 

circumstances by a qualified ME based 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 6233 

on the physical qualification standards 

and medical best practices. 

On January 15, 2013, FMCSA 

announced in a Notice of Final 

Disposition titled, ‘‘Qualification of 

Drivers; Exemption Applications; 

Epilepsy and Seizure Disorders,’’ (78 FR 

3069), its decision to grant requests from 

22 individuals for exemptions from the 

regulatory requirement that interstate 

CMV drivers have ‘‘no established 

medical history or clinical diagnosis of 

epilepsy or any other condition which 

is likely to cause loss of consciousness 

or any loss of ability to control a CMV.’’ 

Since that time, the Agency has 

published additional notices granting 

requests from individuals for 

exemptions from the regulatory 

requirement regarding epilepsy found in 

§ 391.41(b)(8). 

To be considered for an exemption 

from the epilepsy and seizure disorders 

prohibition in § 391.41(b)(8), applicants 

must meet the criteria in the 2007 

recommendations of the Agency’s 

Medical Expert Panel (78 FR 3069). 

III. Qualifications of Applicants 

Andrew Anzalone 

Mr. Anzalone is a 24-year old class 

DM license holder in Massachusetts. He 

has a history of epilepsy and has been 

seizure free since 2010. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2010. His physician states that he is 

supportive of Mr. Anzalone receiving an 

exemption. 

Anthony Cavaliere 

Mr. Cavaliere is a 33-year old class 

BM license holder in New York. He had 

a generalized cerebral concussion and 

has been seizure free since 2010. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2011. His physician states 

that he is supportive of Mr. Cavaliere 

receiving an exemption. 

Shane Chacon 

Mr. Chacon is a 53-year old class A 

license holder in Idaho. He has a history 

of epilepsy and has been seizure free 

since 1997. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2019. His physician states that he is 

supportive of Mr. Chacon receiving an 

exemption. 

Brad Crawford 

Mr. Crawford is a 38-year old class E 

license holder in Louisiana. He has a 

history of generalized epilepsy and has 

been seizure free since 2013. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2015. His physician states that he is 

supportive of Mr. Crawford receiving an 

exemption. 

Michael Davee 

Mr. Davee is a 54-year old class C 

license holder in California. He had a 

single, provoked seizure in October 

2017. He does not take anti-seizure 

medication. His physician states that he 

is supportive of Mr. Davee receiving an 

exemption. 

Callon Hegman 

Mr. Hegman is a 26-year old class E 

license holder in Missouri. He has a 

history of juvenile absence epilepsy and 

has been seizure free since 2012. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2017. His physician states 

that he is supportive of Mr. Hegman 

receiving an exemption. 

Jacob Hitchcock 

Mr. Hitchcock is a 31-year old class C 

license holder in Iowa. He has a history 

of non-intractable epilepsy and has been 

seizure free since May 2010. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2010. His physician states that he is 

supportive of Mr. Hitchcock receiving 

an exemption. 

Holly Hobert 

Ms. Hobert is a 27-year old class O 

license holder in Nebraska. He has a 

history of generalized epilepsy and has 

been seizure free since 2013. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2016. His physician states that he is 

supportive of Ms. Hobert receiving an 

exemption. 

Gary Johnson 

Mr. Johnson is a 49-year old class E 

license holder in Missouri. He has a 

history of chronic epilepsy and has been 

seizure free since March 2012. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2015. His physician states that he is 

supportive of Mr. Johnson receiving an 

exemption. 

Gregory Johnson 

Mr. Johnson is a 44-year old class C 

license holder in North Carolina. He has 

a history of seizures and has been 

seizure free since June 2011. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2013. His physician states that he is 

supportive of Mr. Johnson receiving an 

exemption. 

Lance Johnson 

Mr. Johnson is a 54-year old class D 

license holder in Tennessee. He has a 

history of complex partial seizures and 

has been seizure free since 2009. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2018. His physician states 

that he is supportive of Mr. Johnson 

receiving an exemption. 

Alan Keil 

Mr. Keil is a 45-year old class three 

license holder in Hawaii. He has a 

history of epilepsy and has been seizure 

free for more than 10 years. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2011. His physician states that he is 

supportive of Mr. Keil receiving an 

exemption. 

Kim Langan 

Mr. Langan is a 59-year old class CM 

license holder in California. He has a 

history of epilepsy and has been seizure 

free since 2013. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2015. His physician states that he is 

supportive of Mr. Langan receiving an 

exemption. 

Armando Macias-Tovar 

Mr. Macias-Tovar is a 34-year old 

class E license holder in Florida. He has 

a history of generalized epilepsy and 

has been seizure free since 2013. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2011. His physician states 

that he is supportive of Mr. MaciasTovar receiving an exemption. 

Christian Mandahl 

Mr. Mandahl is a 31-year old class D 

license holder in Montana. He has a 

history of primary generalized epilepsy 

and has been seizure free since 2012. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2012. His physician states 

that he is supportive of Mr. Mandahl 

receiving an exemption. 

Joseph Mendoza 

Mr. Mendoza is a 48-year old operator 

license holder in Indiana. He has a 

history of seizure disorder and has been 

seizure free since 1996. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2013. His physician states that he is 

supportive of Mr. Mendoza receiving an 

exemption. 

Edna Merritt 

Ms. Merritt is a 59-year old class D 

license holder in Tennessee. She has a 


khammond on DSKJM1Z7X2PROD with NOTICES
6234 Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 

history of partial complex seizure 

disorder and has been seizure free since 

2010. She takes anti-seizure medication 

with the dosage and frequency 

remaining the same since 2007. Her 

physician states that he is supportive of 

Ms. Merritt receiving an exemption. 

Richard Packer 

Mr. Packer is a 33-year old class A 

license holder in Idaho. He has a history 

of non-intractable generalized 

idiopathic epilepsy and has been 

seizure free since 2003. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2003. His physician states that he is 

supportive of Mr. Packer receiving an 

exemption. 

Alexander Paradis 

Mr. Paradis is a 24-year old class 10 

license holder in Rhode Island. He has 

a history of focal epilepsy and has been 

seizure free since 2010. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2016. His physician states that he is 

supportive of Mr. Paradis receiving an 

exemption. 

Steven Paul 

Mr. Paul is a 60-year old class DM 

license holder in Wisconsin. He has a 

history of seizure disorder and has been 

seizure free since 2012. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2013. His physician states that he is 

supportive of Mr. Paul receiving an 

exemption. 

Kevin Podman 

Mr. Podman is a 48-year old 

commercial driver’s license (CDL) 

holder in Illinois. He has a history of an 

unprovoked, one-time, generalized 

tonic-clonic seizure and has been 

seizure free since 2014. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2014. His physician states that he is 

supportive of Mr. Podman receiving an 

exemption. 

Michael Reimer 

Mr. Reimer is a 37-year old class C 

license holder in California. He has a 

history of epilepsy and has been seizure 

free since 2012. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2012. His physician states that he is 

supportive of Mr. Reimer receiving an 

exemption. 

Richard Riley 

Mr. Riley is a 66-year old class A 

license holder in Iowa. He has a history 

of a single generalized nocturnal seizure 

and has been seizure free since August 

6, 2020. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

August 6, 2020. His physician states that 

he is supportive of Mr. Riley receiving 

an exemption. 

Charles Rivet 

Mr. Rivet is a 43-year old class 10 

license holder in Iowa. He has a history 

of complex partial seizure disorder and 

has been seizure free since 2013. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2012. His physician states 

that he is supportive of Mr. Rivet 

receiving an exemption. 

Brian Runk 

Mr. Runk is a 31-year old class A 

license holder in Pennsylvania. He has 

a history of a single, unprovoked, 

nocturnal seizure and has been seizure 

free since 2016. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2017. His physician states that he is 

supportive of Mr. Runk receiving an 

exemption. 

Lucas Schmidt 

Mr. Schmidt is a 41-year old class D 

license holder in New York. He has a 

history of epilepsy and has been seizure 

free since 1997. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same for more 

than 10 years. His physician states that 

he is supportive of Mr. Schmidt 

receiving an exemption. 

Bradley Scruggs 

Mr. Scruggs is a 27-year old class A 

license holder in California. He has a 

history of focal awareness seizures and 

has been seizure free since 2007. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2015. His physician states 

that he is supportive of Mr. Scruggs 

receiving an exemption. 

Kacen Shaffer 

Mr. Shaffer is a 22-year old class R 

license holder in Colorado. He has a 

history of epilepsy and has been seizure 

free since 2013. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2014. His physician states that he is 

supportive of Mr. Shaffer receiving an 

exemption. 

Shaen Smith 

Mr. Smith is a 53-year old class D 

license holder in Minnesota. He has a 

history of localization-related epilepsy 

and has been seizure free since 1998. He 

takes anti-seizure medication with the 

dosage and frequency remaining the 

same since 2015. His physician states 

that he is supportive of Mr. Smith 

receiving an exemption. 

Kip West 

Mr. West is a 53-year old class R 

license holder in Colorado. He has a 

history of seizures and has been seizure 

free since 1985. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

1985. His physician states that he is 

supportive of Mr. West receiving an 

exemption. 

Derek Wettstein 

Mr. Wettstein is a 37-year old class C 

license holder in Texas. He has a history 

of idiopathic epilepsy and epileptic 

syndrome, not intractable, without 

status epilepticus and has been seizure 

free since 2004. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2004. His physician states that he is 

supportive of Mr. Wettstein receiving an 

exemption. 

Jeremy Williams 

Mr. Williams is a 19-year old CDL 

holder in Mississippi. He has a history 

of a single unprovoked seizure and has 

been seizure free since 2017. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2018. His physician states that he is 

supportive of Mr. Williams receiving an 

exemption. 

IV. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

under the DATES section of the notice. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–02203 Filed 2–2–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2022–0031] 

Qualification of Drivers; Exemption 

Applications; Hearing 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 


khammond on DSKJM1Z7X2PROD with NOTICES